In conclusion, as the fusion protein BCR-ABL can actively modulate β-catenin levels in the cells, the most severely affected Wnt-pathway in CML is the canonical Wnt pathway. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.